Pharmacogenomic study in multiple sclerosis patients responders and non-responders to interferon-β

被引：0
|
作者：
Bustamante, M.
Morcillo-Suarez, C.
Malhotra, S.
Brassat, D.
Goertsches, R.
Lechner-Scott, J.
Urcelay, E.
Fernandez, O.
Drulovic, J.
Garcia-Merino, A.
Martinelli-Boneschi, F.
Chan, A.
Vandenbroeck, K.
Navarro, A.
Rio, J.
Akkad, D.
Giacalone, G.
Sanchez, A.
Leyva, L.
Alvarez-Lafuente, R.
Zettl, U.
Rodriguez-Antigueedad, A.
Killestein, J.
Oksenberg, J.
Montalban, X.
Comabella, M.
机构：
[1] Vall Hebron Univ Hosp, Barcelona, Spain
[2] Inst Evolutionary Biol UPF CSIC, Barcelona, Spain
[3] Univ Toulouse, Toulouse, France
[4] Univ Rostock, D-18055 Rostock, Germany
[5] Hosp Clin San Carlos, Madrid, Spain
[6] Hosp Reg Univ Carlos Haya, Malaga, Spain
[7] Univ Belgrade, Belgrade, Serbia
[8] Hosp Univ Puerta de Hierro, Madrid, Spain
[9] Ist Sci San Raffaele, I-20132 Milan, Italy
[10] Univ Bochum, Bochum, Germany
[11] Univ Basque Country, Leioa, Spain
[12] ICREA, Barcelona, Spain
[13] Hosp Basurto, Bilbao, Spain
[14] Vrije Univ Med Ctr, Amsterdam, Netherlands
[15] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：503 / 503
页数：1
相关论文
共 50 条
  • [31] A cross-sectional comparison of performance, neurophysiological and MRI outcomes of responders and non-responders to fampridine treatment in multiple sclerosis - An explorative study
    Mamoei, Sepehr
    Jensen, Henrik Boye
    Dalgas, Ulrik
    Zijdewind, Inge
    Pedersen, Andreas Kristian
    Nygaard, Mikkel Karl Emil
    Eskildsen, Simon Fristed
    Stenager, Egon
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 82 : 179 - 185
  • [32] Identification of responders and non-responders to imatinib prior to treatment
    Otahalova, E.
    Lebowitz, M. S.
    Ghanbari, H. A.
    EJC SUPPLEMENTS, 2006, 4 (12): : 81 - 81
  • [33] A randomized trial of ribavirin and interferon-α vs. interferon-α alone in patients with chronic hepatitis C who were non-responders to a previous treatment
    Pol, S
    Couzigou, P
    Bourlière, M
    Abergel, A
    Combis, JM
    Larrey, D
    Tran, A
    Moussalli, J
    Poupon, R
    Berthelot, P
    Bréchot, C
    JOURNAL OF HEPATOLOGY, 1999, 31 (01) : 1 - 7
  • [34] CHARACTERISTICS OF RESPONDERS AND NON-RESPONDERS TO A DENTAL RECALL NOTICE
    CECIL, JC
    COHEN, ME
    MCCARTHY, TP
    JOURNAL OF DENTAL RESEARCH, 1981, 60 : 425 - 425
  • [35] Issues in the determination of 'responders' and 'non-responders' in physiological research
    Atkinson, Greg
    Williamson, Philip
    Batterham, Alan M.
    EXPERIMENTAL PHYSIOLOGY, 2019, 104 (08) : 1215 - 1225
  • [36] METABOLIC RESPONDERS AND NON-RESPONDERS TO MUSCULAR EXERCISE IN DIABETES
    IONESCUTIRGOVISTE, C
    MINCU, I
    MIHALACHE, N
    IONESCU, C
    APETREI, E
    REVUE ROUMAINE DE MEDECINE-MEDECINE INTERNE, 1980, 18 (03): : 293 - 307
  • [37] Cytokines in patients with chronic hepatitis C:: Comparison between responders and non-responders to interferon alfa2b.
    Fernández, JL
    Silva, M
    Eiras, G
    Rendo, P
    Pérez, V
    Vidal, A
    Criscuolo, M
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 462 - 462
  • [38] Genomic profiles in patients with chronic migraine: responders vs. non-responders
    Hershey, AD
    Powers, SW
    Kabbouche, MA
    Burdine, D
    Glauser, TA
    Tang, Y
    Sharp, FR
    CEPHALALGIA, 2005, 25 (10) : 852 - 853
  • [39] Infliximab Induces Regulatory Macrophages in Responders but Not in Non-Responders
    Vos, Anne Christine W.
    Wildenberg, Manon E.
    Arijs, Ingrid
    Duijvestein, Marjolijn
    Verhaar, Auke
    Vermeire, Severine
    van den Brink, Gijs R.
    Rutgeens, Paul A.
    Hommes, Daniel W.
    GASTROENTEROLOGY, 2011, 140 (05) : S274 - S274
  • [40] Clinical characteristics of non-responders and super-responders
    Hua, Wei
    CIRCULATION, 2012, 125 (19) : E720 - E720
12345